Home
Resources
Publications
Withanoside IV and Its Active Metabolite, Sominone, Attenuate Abeta(25-35)-induced Neurodegeneration

Withanoside IV and Its Active Metabolite, Sominone, Attenuate Abeta(25-35)-induced Neurodegeneration

Tomoharu Kuboyama, Chihiro Tohda, Katsuko Komatsu

Eur J Neurosci. 2006 Mar;23(6):1417-26.

PMID: 16553605

Abstract:

At the present, medication of dementia is limited to symptomatic treatments such as the use of cholinesterase inhibitors. To cure dementia completely, that is regaining neuronal function, reconstruction of neuronal networks is necessary. Therefore, we have been exploring antidementia drugs based on reconstructing neuronal networks in the damaged brain and found that withanoside IV (a constituent of Ashwagandha; the root of Withania somnifera) induced neurite outgrowth in cultured rat cortical neurons. Oral administration of withanoside IV (10 micromol/kg/day) significantly improved memory deficits in Abeta(25-35)-injected (25 nmol, i.c.v.) mice and prevented loss of axons, dendrites, and synapses. Sominone, an aglycone of withanoside IV, was identified as the main metabolite after oral administration of withanoside IV. Sominone (1 microM) induced axonal and dendritic regeneration and synaptic reconstruction significantly in cultured rat cortical neurons damaged by 10 microM Abeta(25-35). These data suggest that orally administrated withanoside IV may ameliorate neuronal dysfunction in Alzheimer's disease and that the active principle after metabolism is sominone.

Chemicals Related in the Paper:

Catalog Number	Product Name	Structure	CAS Number	Price
AP362472819	Withanoside IV		362472-81-9	Price

As a specialist in analytical chemical Products, Alfa Chemistry offers consumers a wealth of raw materials and a full range of technologies and services.

QUICK LINKS

HEADQUARTERS

Tel:

Fax:

Email: